Barron's - USA (2020-12-07)

(Antfer) #1

38 BARRON’S December 7, 2020


INCOME INVESTING


U


ntil value stocks perked up in


recent weeks on the positive


news about Covid vaccines,


many dividend stocks had


languished this year.


Some dividend strategies worked bet-


ter than others, however, before the ro-


tation into value.


“Investors have preferred to focus on


companies with a long-term history of


increasing their dividend,” Chris Senyek,


chief investment strategist at Wolfe Re-


search, wrote in a recent note. Mean-


while, he added, they “largely avoided


dividend-yielding stocks this year over


dividend cut concerns and their ‘value’


investment style tilt.”


Consistent dividend growth over at


least 25 years was the best-performing


basket of dividend stocks tracked by


Wolfe Research. Senyek’s list of about 65


stocks that meet those criteria include


many of the S&P 500 Dividend Aristo-


crats. Members of that group have paid


out a higher dividend every year for at


least 25 years.


The Aristocrats, which includeJohn-


son & Johnson(ticker: JNJ),Target


(TGT), andMcDonald’s(MCD), have


returned 7.5% this year, dividends in-


cluded, as of Dec. 1. That compares with


a 15.3% result for the S&P 500 through


the same date.


As is the case for many dividend


stocks, 2020 performance has been a


tale of two distinct periods for the Aris-


tocrats. (See page 17 for dividend payers


benefiting from the recent rotation into


value stocks.)


From Dec. 31 of last year through Nov.


6, the Aristocrats eked out a return of


about 1%. But the Nov. 9 news from


Pfizer(PFE) andBioNTech(BNTX)


that their Covid vaccine was more than


90% effective marked the beginning of a


rotation into value stocks—and a boon


for many dividend stocks. From Nov. 6


through Dec. 1, the Aristocrats returned


6.3%.


The top-performing Aristocrats this


year hail from a variety of sectors.


Albemarle(ALB), a specialty chemi-


cal company and lithium miner, finished


first with a total return of 88%. The


shares have benefited in part from opti-


mism about future lithium sales for bat-


teries used to power electric vehicles.


The stock, however, yields 1.1%, one


of the lowest among the Aristocrats. Its


strong year-to-date performance was


followed by Target, up 40%, dividends


included;Clorox(CLX), up 34%; and


Cintas(CTAS), which gained 35%. Cin-


tas, whose products include employee


uniforms, yields 0.8%. Clorox was at


2.2%, and Target was at 1.5%.


A


s one might expect given the


inverse relationship between


price performance and yield,


the highest-yielding Aristocrats


have been among the worst performers


in 2020.


At 9% recently,Exxon Mobil(XOM)


sports the highest yield and, with a re-


turn of about minus 40%, it has been


the worst-performing Aristocrat this


year as of Dec. 1. The company, which


has struggled with lower oil prices, has


maintained its quarterly dividend at 87


cents a share, the first time in early 40


years that it hasn’t boosted the payout.


However, the stock will remain in the


Aristocrats for now because it will have


paid out more in dividends this year


than it did in 2019.


Other laggards in the group include


AT&T(T), down 21%;Walgreens


Boots Alliance(WBA), off 32%; and


Chevron(CVX), which has lost 23%,


including dividends.


But as a group, the Aristocrats have


been a solid option for defensive investors


during the pandemic. One way to play


that is with theProShares S&P 500


Dividend AristocratsETF (NOBL).B


By Lawrence C. Strauss


THE ECONOMY


Covid Spike Hits Hiring,


And It’s Likely to Worsen


T


he economy may not have


shrunk in November, despite


the resurgence of the corona-


virus and the continued un-


winding of government support. But


that’s thin gruel to the roughly 12 million


Americans who remain underemployed


compared with February.


Employers reported 338,000 addi-


tional jobs last month, according to the


Department of Labor’s latest nonfarm


payrolls report, after excluding layoffs


associated with the end of the census. A


year ago, that would have been a strong


number, but relative to the magnitude of


the jobs gap, it represents something close


to stagnation. After all, the private sector


added an average of 945,000 jobs each


month from August through October.


Moreover, the underlying details of


the data suggest that the U.S. job market


could easily turn negative in the months


ahead, assuming it hasn’t already. That


risks inflicting hardship on tens of mil-


lions of people while we wait for the


vaccine to be widely distributed.


Big hiring numbers for delivery and


warehouse services—which together


added about 120,000 jobs—offset outright


declines in a wide range of sectors, includ-


ing retail, restaurants, schools, tech, pub-


lishing, banking, accounting, consulting,


and nursing homes, which together lost


almost 120,000 jobs. Meanwhile, there


was almost no job growth in many other


sectors, including construction, manufac-


turing, personal services, hospitals, and


local governments excluding education.


The hit to retail and restaurants can


probably be explained by the resurgence


of the virus—and that hit will probably


worsen in coming months due to the


soaring number of new confirmed cases.


The current jobs report, after all, is a


snapshot of the week ended on Nov. 14,


when there were 993,000 new cases, up


from 383,000 new confirmed cases in the


corresponding October week. In the past


seven days, there were more than 1.2 mil-


lion new cases.


At least as concerning as the retail and


restaurant hit is the continuing weakness


in professional-services employment,


which reflects the spread of the economic


pain from directly affected sectors to the


rest of society. In percentage terms, the


monthly drop in employment at “com-


puter systems design and related ser-


vices” was twice as bad as the decline at


restaurants and bars. As ofNovember,


employment across America’s total tech


sector was down about 2.2% compared


with February. That’s worse than the


peak-to-trough decline in 2008-09.


P


erhaps the biggest warning sign


of a negative turn comes from the


jobs report’s separate survey of


households, which implies that


employment fell by about 450,000 after


accounting for the sharp increase in the


number of workers who were probably


misclassified as “employed with an un-


paid absence.” At 0.3%, the implied drop


in November employment is comparable


to what’s happening in tech, restaurants,


retail, and public schools.


The number of people counted as


unemployed barely dropped, thanks to


a downtick in people reporting they were


on “temporary layoff”—but that was only


because 400,000 Americans stopped


actively looking for work due to a lack of


jobs. As a result, there are still 12 million


Americans who are either out of work


or who are working part time but would


prefer to have full-time jobs.


With multiple vaccines ready to be


distributed, it’s likely that the economy


will be able to rebound strongly before


the end of next year. It’s also likely that


things will continue to get worse before


they get better, and that the potential for


permanent damage to workers and busi-


nesses will rise the longer Americans go


without income support.B


By Matthew C. Klein


BestBetinaDownYear:


The Dividend Aristocrats

Free download pdf